Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 5026 - 5050 of 5801 in total

Etavopivat

Etavopivat is a small molecule activator of erythrocyte pyruvate kinase (PKR) under investigation for the treatment of sickle cell disease.
Investigational

PVX-410 component XBP1 US184-192(YISPWILAV)

Investigational

Contulakin-G

Contulakin-G is a broad spectrum non-opioid analgesic. It is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail.
Investigational

D-threo-neopterin

A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.
Experimental

[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium

Experimental

(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid

Experimental

(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid

Experimental

3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide

Experimental

(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE

Experimental

Vamifeport

Vamifeport is being investigated for the treatment of beta-thalassemia.
Investigational

Soquelitinib

Investigational

ADH-1

Adherex's biotechnology compound, ADH-1, targets N-cadherin, a protein present on certain tumor cells and established tumor blood vessels. ADH-1 is currently in clinical development in a combination program with a range of chemotherapeutic agents to investigate the synergistic effects noted in our preclinical models. At the end of 2006, the...
Investigational
Matched Description: … Adherex's biotechnology compound, ADH-1, targets N-cadherin, a protein present on certain tumor cells …

Triglu-5-formyl-tetrahydrofolate

Experimental

N-Methyl-N-(Methylbenzyl)Formamide

Experimental

Deoxy-2-fluoro-beta-D-cellotrioside

Experimental
Investigational

2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)

Experimental

NUC B1000

NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct designed to produce four short interfering RNA (siRNA) molecules, formulated with a proprietary cationic-lipid delivery system. eiRNA is an approach to RNAi therapeutics, whereby a plasmid DNA coding for desired dsRNA is delivered to...
Investigational
Matched Description: … B1000 was entering a phase 1 human safety study of its experimental treatment for chronic Hepatitis B virus …

N,N-dimethylformamide

Experimental

CR002

CR002 is a novel investigational fully human monoclonal antibody that blocks the activity of excess platelet-derived growth factor-D (PDGF-D), a target shown to play a role in kidney inflammation. This is a novel therapeutic approach to treat kidney inflammation.
Investigational

Setogepram

Setogepram is under investigation in clinical trial NCT03184584 (Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome).
Investigational

Exisulind

Investigational

Imalumab

Imalumab is under investigation in clinical trial NCT02540356 (Phase 1/2a Two-arm Dose-escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer).
Investigational

PHI-101

Investigational

N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide

Experimental

Naproxcinod

Investigational
Displaying drugs 5026 - 5050 of 5801 in total